Patent · US Revoked

Short-acting heparin-based anticoagulant compounds and methods

US11701380B2 · kind B2 · utility

0Cited by
14References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2018
Grant dateJul 18, 2023
Priority date
Expiry dateMar 12, 2038

Classification

  • Technology area (CPC —)General

Abstract

Heparin compounds and synthetic heparin analogues having short acting anticoagulant activity are provided. Methods of synthesizing such heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes are provided. Methods of treating subjects in need of anticoagulant activity are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.